weight loss pills

Abbott Pulls Weight Loss Drug Meridia from Market

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

A Victory Against False Advertising in Relacore Lawsuits

The N.J. Supreme Court gave a win to advocates of truth in advertising this week when it ruled that lawsuits against the maker of dietary supplement Relacore could go forward as a class action. Considering the way such lawsuits work, gaining that status is almost as important as the final verdict.